Maravai LifeSciences (MRVI) Misses Q1 EPS by 6c

Maravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $60.55 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• RBC Capital Reiterates Sector Perform Rating on ExxonMobil (XOM)
• Faraday Future unveils nine robotics devices priced from $9,990